Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, 2 Part Study to Assess the Efficacy and Safety of Acthar Gel in Subjects With Rheumatoid Arthritis With Persistently Active Disease Despite Dual-DMARD Treatment

NCT02919761 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.

NCT NCT02919761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02919761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, 2 Part Study to Assess the Efficacy and Safety of Acthar Gel in Subjects With Rheumatoid Arthritis With Persistently Active Disease Despite Dual-DMARD Treatment
Lead sponsor
Mallinckrodt
Phase
Phase 4
Overall status
Completed
Start date
November 7, 2016
Completion date
February 13, 2019
Enrollment
259 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid